MindMap Gallery inhalation anesthesia, medicine
Anesthesiology, pharmacology of anesthesia. Summary of knowledge points on inhaled anesthetics, with a detailed overview of the physical and chemical properties and classification, pharmacokinetics, pharmacodynamics, and content of inhaled anesthetics commonly used in clinical practice.
Edited at 2022-04-24 16:32:55This is a mind map about bacteria, and its main contents include: overview, morphology, types, structure, reproduction, distribution, application, and expansion. The summary is comprehensive and meticulous, suitable as review materials.
This is a mind map about plant asexual reproduction, and its main contents include: concept, spore reproduction, vegetative reproduction, tissue culture, and buds. The summary is comprehensive and meticulous, suitable as review materials.
This is a mind map about the reproductive development of animals, and its main contents include: insects, frogs, birds, sexual reproduction, and asexual reproduction. The summary is comprehensive and meticulous, suitable as review materials.
This is a mind map about bacteria, and its main contents include: overview, morphology, types, structure, reproduction, distribution, application, and expansion. The summary is comprehensive and meticulous, suitable as review materials.
This is a mind map about plant asexual reproduction, and its main contents include: concept, spore reproduction, vegetative reproduction, tissue culture, and buds. The summary is comprehensive and meticulous, suitable as review materials.
This is a mind map about the reproductive development of animals, and its main contents include: insects, frogs, birds, sexual reproduction, and asexual reproduction. The summary is comprehensive and meticulous, suitable as review materials.
inhalation anesthetic
Physical and chemical properties and classification
Category: Volatile inhalation anesthetics, gas inhalation anesthetics
Blood gas distribution coefficient: refers to the ratio of anesthetic drug concentration in the blood and alveolar gas phases when the partial pressures are equal, that is, when dynamic equilibrium is reached.
A large blood gas distribution coefficient indicates high solubility in blood - easy to dissolve. A slow rise in the anesthetic concentration in the blood means slow induction and a slow fall means a longer recovery period.
Low blood gas distribution coefficient and low metabolic rate in the body are the research directions of new inhalation anesthetics.
Pharmacokinetics
The speed of entering the alveoli
Inhalation concentration
Concentration effect: refers to the positive correlation between the inhalation concentration and the concentration of the alveolar anesthetic. The higher the inhalation concentration, the faster it enters the alveoli, the faster the alveolar anesthetic concentration PA rises, and the faster the anesthetic partial pressure Pa in the blood rises. To shorten the induction period of anesthesia, a higher concentration should be inhaled at the beginning of anesthesia.
Second gas effect: When high-concentration gas and low-concentration gas are inhaled at the same time, the alveolar concentration and blood concentration of the low-concentration gas (second gas) increase faster than when the same low-concentration gas is used alone. --Concentration effect, incremental effect.
Pulmonary ventilation: Increasing alveolar ventilation has a significant impact on anesthetics with high solubility in blood.
speed into blood
Uptake = λ
speed of entry into organization
Solubility of anesthetics in tissues; local blood flow in tissues; partial pressure difference between arterial blood and anesthetics in tissues
excretion
If most of the anesthetic is excreted through the lungs, if the anesthesia is too deep, in addition to stopping the drug immediately, ventilation should be increased to accelerate the excretion of the anesthetic.
Pharmacodynamics
Minimum alveolar effective concentration, MAC: refers to the end-expiratory tidal volume (equivalent to alveolar air) at one atmospheric pressure that prevents 50% of patients or animals from producing physical responses (escape reflexes) to harmful stimuli (such as surgical incision). The concentration of the anesthetic. Unitvol%
For potency strength, analgesia ED50
Can be measured repeatedly, frequently and accurately, reflecting the partial pressure in the brain
The dose-response curve is steep, 1.3 MAC ≈ED95, commonly used
Each inhaled general anesthetic drug is “added” into the MAC
Species, gender, day and night, thyroid function, type of stimulation, duration of anesthesia, and mild changes in PaCO2 and PaO2 do not affect MAC
The effects of age, pregnancy, body temperature, combined medication, etc.
clinical significance
Reflects the effectiveness of inhaled anesthetics---the greater the MAC value, the smaller the anesthetic effectiveness
Determine the depth of inhalation anesthesia
MAC extension value
1. Half-awake alveolar air concentration (MACawake50): The alveolar air inhalation anesthetic concentration when 50% of patients can open their eyes in response to a simple command is approximately (1/4~1/3 MAC) 2. 95% effective dose (MAC95): The alveolar air inhalation anesthetic concentration when 95% of people are exposed to noxious stimulation and do not move, is about 1.3 MAC, which is equivalent to ED95 3. Half of the endotracheal intubation alveolar air concentration (MAC EI50): 1.5 MAC 4. MACBAR: alveolar air inhalation anesthetic concentration that blocks autonomic nervous response: 1.7 MAC
Factors affecting MAC
Factors that reduce the MAC of inhaled anesthetics (more sensitive to inhaled anesthetics): age↑, hypothermia, concomitant medications, pregnancy, central nervous system hypotonicity, acute heavy drinking
Factors that increase the MAC of inhaled anesthetics (not sensitive to inhaled anesthetics): age, elevated body temperature, drugs that excite the central nervous system, chronic alcoholism, and central nervous system hypertonicity
Effects of inhaled anesthetics on various organ systems
respiratory system
Respiratory depression - dose dependent
Inhibits bronchial smooth muscle contraction, effective for asthma patients
Airway irritation - positive correlation with inhaled concentration
On ischemic pulmonary vasoconstriction (HPV): animal experiments-inhaled anesthetics inhibit ischemic pulmonary vasoconstriction in a dose-dependent manner
circulatory system
Dose-related effects on blood pressure, heart rate and peripheral vascular resistance--inhibition of myocardial contractility
Arrhythmogenic effect---halothane causes ventricular premature
Coronary arteries--Isoflurane has a strong dilation effect on coronary arteries
Central Nervous System
Cerebral blood flow↑
Brain metabolic rate↓
intracranial pressure↑
Electroencephalogram - suppression, but desflurane or isoflurane has no such effect, so it is suitable for neurosurgery anesthesia
liver
Liver blood flow↓
liver function
kidney
Renal blood flow, glomerular filtration rate and urine output↓
nephrotoxicity
The protective effect of inhaled anesthetics on organs---especially has a certain protective effect on ischemia-reperfusion injury of multiple organs
cardioprotection
PKC-activated, ATP-sensitive potassium channel
brain protection
lung protection
ischemia reperfusion injury
liver protection
Inhibit inflammatory response
Commonly used clinical inhalation anesthetics
Sevoflurane
The blood/gas distribution coefficient is only 0.69 - induction and quick recovery
Hydrolyzed in the liver, metabolic rate 3%
Pharmacological effects
Central Nervous System
General anesthesia is highly effective, with a MAC value of 1.71%
During light anesthesia, rhythmic slow waves appear in the EEG, and as the anesthesia deepens, the slow waves gradually Gradually decrease, and a spike wave group similar to the appearance of barbiturates appears. Sevoflurane can also cause generalized spasm when the anesthesia is too deep, but it is weaker than enflurane and there is no clinical concern about this.
Sevoflurane also increases cerebral blood flow, increases intracranial pressure, and reduces cerebral oxygen consumption, but this effect is weaker than that of halothane.
Has a certain muscle relaxant effect
circulatory system
Dose-dependent inhibitory effect on circulatory system
respiratory system
Sevoflurane causes very little irritation to the airways
Respiratory depression worsens as anesthesia deepens
Sevoflurane does not inhibit pulmonary vasoconstriction in response to hypoxia
liver
Hepatic blood flow decreases after sevoflurane anesthesia, but quickly returns to normal after anesthesia ends. There is almost no possibility of liver toxicity.
Kidney---little impact
Sevoflurane reacts with soda-lime to form Complex A. The kidneys uptake Complex A-glutathione or Complex A-cysteine conjugates. β-lyase catabolizes cysteine conjugates to mediate Compound A-induced renal injury in experimental rats. -----Species differences
Clinical application
Advantages: rapid induction, non-irritating, quick recovery, easy to control the depth of anesthesia
Indications: Can be used by all patients who require general anesthesia
Disadvantages: unstable in the presence of soda lime
Contraindications: ①Those who have liver damage after using inhaled general anesthesia within 1 month; ② If you or your family members are allergic to halogenated anesthetics or have malignant hyperthermia; ③Use with caution in those with poor liver and kidney function.
Adverse reactions 13%
Nausea and vomiting (3.67%) Arrhythmia (2.79%) Hypotension (2.71%)
Desflurane
Pharmacological effects
Central Nervous System
The anesthetic effect of desflurane is weak, with a MAC value of 7% and a blood gas distribution coefficient of 0.42. Quick induction and recovery
Satisfactory muscle relaxant effect
circulatory system
Inhibits circulatory function in a dose-dependent manner, reduces myocardial contractility, cardiac output, peripheral vascular resistance and blood pressure, and rarely causes arrhythmias.
One of the outstanding advantages of desflurane is its small impact on cardiovascular function.
respiratory system
It dose-dependently inhibits respiration, reduces minute ventilation, increases PaCO2, and enhances the body's ventilatory response to increased PaCO2.
Little effect on liver function
No significant impact on kidneys
Clinical application
advantage
0.42 Low solubility in blood and tissue, fast anesthesia induction and recovery
0.02% has little biotransformation in the body and has little impact on the body.
It has little interference with circulatory function and is more suitable for anesthesia during cardiovascular surgery.
The neuromuscular blocking effect is stronger than other fluorinated alkanes inhalation anesthetics
shortcoming
An evaporator with a low boiling point that requires a special electronic device to control the temperature
pungent smell
Increased sympathetic activity
Generate CO
Isoflurane
Physical and chemical properties
Except for a slightly pungent odor, the physical and chemical properties are close to ideal properties.
internal processes
There is little biological transformation in the body, and almost all of it is exhaled from the lungs in its original form.
Pharmacological effects
anesthetic potency
The blood/gas distribution coefficient is only 1.41
High general anesthesia efficacy: MAC (1.15%)
Central Nervous System
The central nervous system depression of isoflurane is dose-related.
It can be used for patients with epilepsy---enflurane-like convulsions will not occur during deep anesthesia, low PaCO2, or when auditory stimulation is applied.
Isoflurane can prevent the increase in intracranial pressure under PaCO2 conditions in craniotomy patients
Suitable for anesthesia in patients with myasthenia gravis---isoflurane can produce sufficient muscle relaxation
circulatory system
The inhibition of cardiac function is less than that of enflurane and halothane
Lowering blood pressure is mainly due to Caused by decreased peripheral vascular resistance
It slightly increases the heart rate, but the heart rate is stable, and can be used if there is ventricular rhythm before surgery. disordered patient
respiratory system
Inhibition of respiration is dose-related, can severely reduce ventilation, increase PaCO2, and inhibit the ventilatory response to increased PaCO2
Anesthesia increases pulmonary resistance and slightly decreases compliance and functional residual capacity
No obvious damage to liver and kidneys
Clinical application
Advantages and indications
①Stable circulation; ②Low toxicity; ③Good muscle relaxation; ④ Dilate coronary arteries, which is beneficial to patients with myocardial ischemia; ⑤ It has no obvious effect on increasing intracranial pressure and is suitable for anesthesia in neurosurgery.
It is suitable for patients with epilepsy, increased intracranial pressure, myasthenia gravis, pheochromocytoma, diabetes, and bronchial asthma. Can be used for controlled blood pressure reduction.
Disadvantages and contraindications
①The price is relatively expensive; ②It has a pungent smell and is generally not used for induction; ③Increase heart rate; ④During deep anesthesia, it is not suitable for obstetric surgery due to increased uterine bleeding; ⑤ A few patients experience nausea, vomiting, salivation, and laryngospasm.
Other inhalation anesthetics
Nitrous oxide (laughing gas)
advantage: ① The least toxic inhalation anesthetic, nitrous oxide is not toxic as long as there is no lack of oxygen; ②Anesthesia induction and recovery are rapid; ③Strong analgesic effect; ④No irritation to airway mucosa; ⑤Non-flammable.
Indications: ① Combined with other inhaled anesthetics and muscle relaxants, it can be used for anesthesia in various surgeries; ② It has little impact on circulatory function and can be used for severe shock or critically ill patients; ③Labor analgesia.
Enflurane
Convulsive spikes are the brain wave characteristics of deep anesthesia and are more likely to be induced when PaCO2 is low.
Moderate analgesic effect, suitable for patients with myasthenia gravis
People with epilepsy and increased intracranial pressure should generally not use it.
Adverse reactions: 1. Inhibit breathing and circulation 2. Central excitement 3. Liver damage: Reports of liver necrosis caused by repeated use. 4. Renal damage: Mild suppression, recovery occurs more than 2 hours after stopping the drug. Use with caution in patients with severe renal impairment.
Halothane
Liver damage-halothane-related hepatitis
Ether